{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:56:06Z","timestamp":1789480566750,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,23]]},"DOI":"10.7759\/cureus.81033","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T15:22:01Z","timestamp":1742743321000},"source":"Crossref","is-referenced-by-count":1,"title":["Complete Resolution of Atypical Paraneoplastic Pemphigus Following Treatment With Dupilumab"],"prefix":"10.7759","author":[{"given":"Gabriela","family":"Pinero-Crespo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skylar","family":"Klager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kowalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Paraneoplastic pemphigus","author":"Kappius RH","year":"2023","unstructured":"Kappius RH, Ufkes NA, Thiers BH. Paraneoplastic pemphigus. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.020","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part I. Clinical overview and pathophysiology","volume":"91","author":"Anderson HJ","year":"2024","unstructured":"Anderson HJ, Huang S, Lee JB. Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part I. Clinical overview and pathophysiology. J Am Acad Dermatol. 2024, 91:1-10. 10.1016\/j.jaad.2023.08.020","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2020.08.029","article-title":"Atypical paraneoplastic pemphigus without mucosal involvement","volume":"113","author":"Ferreira S","year":"2022","unstructured":"Ferreira S, Machado \u00c1, Sanches M, Selores M. Atypical paraneoplastic pemphigus without mucosal involvement. Actas Dermosifiliogr. 2022, 113:519-21. 10.1016\/j.ad.2020.08.029","journal-title":"Actas Dermosifiliogr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14004","article-title":"Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis","volume":"48","author":"Svoboda SA","year":"2021","unstructured":"Svoboda SA, Huang S, Liu X, Hsu S, Motaparthi K. Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis. J Cutan Pathol. 2021, 48:1133-8. 10.1111\/cup.14004","journal-title":"J Cutan Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.084","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part II. Diagnosis and management","volume":"91","author":"Huang S","year":"2024","unstructured":"Huang S, Anderson HJ, Lee JB. Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: part II. Diagnosis and management. J Am Acad Dermatol. 2024, 91:13-22. 10.1016\/j.jaad.2023.08.084","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim JH","year":"2019","unstructured":"Kim JH, Kim SC. Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa. Front Immunol. 2019, 10:1259. 10.3389\/fimmu.2019.01259","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2022.010","article-title":"The assessment of severe cutaneous adverse drug reactions","volume":"45","author":"Copaescu AM","year":"2022","unstructured":"Copaescu AM, Trublano JA. The assessment of severe cutaneous adverse drug reactions. Aust Prescr. 2022, 45:43-8. 10.18773\/austprescr.2022.010","journal-title":"Aust Prescr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(99)00016-x","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai M","year":"1999","unstructured":"Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci. 1999, 20:92-102. 10.1016\/s0923-1811(99)00016-x","journal-title":"J Dermatol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.10.035","article-title":"Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris","volume":"31","author":"Moore AY","year":"2023","unstructured":"Moore AY, Hurley K. Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris. JAAD Case Rep. 2023, 31:16-8. 10.1016\/j.jdcr.2022.10.035","journal-title":"JAAD Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.09.018","article-title":"Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus","volume":"42","author":"Jiang C","year":"2023","unstructured":"Jiang C, Adjei S, Santiago S, Lu J, Duran M, Tyring S. Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus. JAAD Case Rep. 2023, 42:12-5. 10.1016\/j.jdcr.2023.09.018","journal-title":"JAAD Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306484-complete-resolution-of-atypical-paraneoplastic-pemphigus-following-treatment-with-dupilumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T15:22:03Z","timestamp":1742743323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306484-complete-resolution-of-atypical-paraneoplastic-pemphigus-following-treatment-with-dupilumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.81033","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,23]]}}}